Foster Dykema Cabot & Partners’s MetLife MET Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-394	Closed	-$32.5K	–	392
2025 Q3	$32.5K	Buy	+394	New	+$31K	﹤0.01%	253

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Foster Dykema Cabot & Partners's MET Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of MetLife (MET) in Q4 2025, closing a stake of 394 shares — an estimated $32.5K sold.

Foster Dykema Cabot & Partners first reported a position in MET in Q3 2025 and held it in 1 quarter. The position peaked at $32.5K in Q3 2025. 1,447 funds tracked by Wall St. Rank hold MET as of Q4 2025.

Foster Dykema Cabot & Partners reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
Foster Dykema Cabot & Partners sold 394 MetLife shares in Q4 2025, an estimated $32.5K.
Foster Dykema Cabot & Partners first reported a position in MetLife in Q3 2025 and held it in 1 quarter.
Foster Dykema Cabot & Partners's MetLife position peaked at $32.5K in Q3 2025.
1,447 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.